| scholarly article | Q13442814 |
| P50 | author | Lee Jia | Q56760986 |
| P2093 | author name string | Jie Wang | |
| Jian Liu | |||
| Chen Zhang | |||
| Junxia Zheng | |||
| Doudou Zhang | |||
| Yusheng Lu | |||
| Bifei Li | |||
| P2860 | cites work | Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics | Q26751009 |
| Cancer treatment and survivorship statistics, 2012 | Q27020961 | ||
| Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility | Q28384598 | ||
| A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA | Q28394647 | ||
| Cancer treatment and survivorship statistics, 2014 | Q29617702 | ||
| Chemically exfoliated MoS2 as near-infrared photothermal agents. | Q30410245 | ||
| Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling | Q33688875 | ||
| Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy | Q35153888 | ||
| Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin. | Q35997124 | ||
| Sodium and Lithium Storage Properties of Spray-Dried Molybdenum Disulfide-Graphene Hierarchical Microspheres | Q36288600 | ||
| Hyaluronan: pharmaceutical characterization and drug delivery | Q36299209 | ||
| Ligand conjugation of chemically exfoliated MoS2 | Q36807011 | ||
| Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles. | Q36951261 | ||
| Liposomes in biology and medicine | Q37064167 | ||
| Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib | Q37851148 | ||
| Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis. | Q37940069 | ||
| Graphene and graphene-like layered transition metal dichalcogenides in energy conversion and storage | Q38191827 | ||
| Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine | Q38603356 | ||
| A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. | Q38702941 | ||
| Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic. | Q38798634 | ||
| Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route | Q38807059 | ||
| Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery | Q38841362 | ||
| Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment. | Q38855146 | ||
| Cancer treatment and survivorship statistics, 2016. | Q38859236 | ||
| Biocompatible PEGylated MoS2 nanosheets: controllable bottom-up synthesis and highly efficient photothermal regression of tumor | Q38932790 | ||
| Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44. | Q38949468 | ||
| Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. | Q39010748 | ||
| Cellular proliferation, cellular viability, and biocompatibility of HA-ZnO composites | Q39439672 | ||
| Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models | Q40238909 | ||
| Layered MoS2 Hollow Spheres for Highly-Efficient Photothermal Therapy of Rabbit Liver Orthotopic Transplantation Tumors | Q40356315 | ||
| Spectroscopic studies on the interaction between erlotinib hydrochloride and bovine serum albumin | Q41880312 | ||
| Li Intercalation in MoS2: In Situ Observation of Its Dynamics and Tuning Optical and Electrical Properties. | Q45944845 | ||
| A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer | Q46106319 | ||
| Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo | Q47135282 | ||
| A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer. | Q47249303 | ||
| Fabrication and atomic structure of size-selected, layered MoS2 clusters for catalysis | Q47436188 | ||
| Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway. | Q47921354 | ||
| Production of mono- to few-layer MoS2 nanosheets in isopropanol by a salt-assisted direct liquid-phase exfoliation method | Q50065176 | ||
| Reflectance calculations of anisotropic dielectric constants of graphene-like two-dimensional materials | Q50093443 | ||
| NANOELECTRONICS. Epitaxial growth of a monolayer WSe2-MoS2 lateral p-n junction with an atomically sharp interface | Q50873872 | ||
| Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects | Q50903923 | ||
| Phase-engineered low-resistance contacts for ultrathin MoS2 transistors. | Q51059139 | ||
| Hysteresis in single-layer MoS2 field effect transistors | Q51369498 | ||
| Effect of ultrasonic degradation of hyaluronic acid extracted from rooster comb on antioxidant and antiglycation activities. | Q51481708 | ||
| Magnetic Graphene Nanosheet-Based Microfluidic Device for Homogeneous Real-Time Electronic Monitoring of Pyrophosphatase Activity Using Enzymatic Hydrolysate-Induced Release of Copper Ion. | Q51628851 | ||
| Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. | Q53095401 | ||
| Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. | Q53336710 | ||
| Adsorption and desorption of tyrosine kinase inhibitor erlotinib on gold nanoparticles | Q54356632 | ||
| Conducting MoS₂ nanosheets as catalysts for hydrogen evolution reaction | Q54572111 | ||
| Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery | Q57166756 | ||
| Molecular Functionalization of 2D MoS2 Nanosheets | Q57470638 | ||
| Self-assembled aptamer-hyperbranched polymer nanocarrier for targeted and photoresponsive drug delivery | Q58615290 | ||
| Reply to 'Measurement of mobility in dual-gated MoS2 transistors' | Q59309536 | ||
| Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer | Q64245271 | ||
| Efficient Degradation of High-Molecular-Weight Hyaluronic Acid by a Combination of Ultrasound, Hydrogen Peroxide, and Copper Ion | Q64267991 | ||
| Polymeric nanoparticles for cancer therapy | Q80701441 | ||
| Tuning the threshold voltage of MoS2 field-effect transistors via surface treatment | Q85280542 | ||
| Synthesized ultrathin MoS2 nanosheets perpendicular to graphene for catalysis of hydrogen evolution reaction | Q86368636 | ||
| A graphitic hollow carbon nitride nanosphere as a novel photochemical internalization agent for targeted and stimuli-responsive cancer therapy | Q86897511 | ||
| Comparative Study of Potential Applications of Graphene, MoS2, and Other Two-Dimensional Materials in Energy Devices, Sensors, and Related Areas | Q87018229 | ||
| Stable 1T-phase MoS2 as an effective electron mediator promoting photocatalytic hydrogen production | Q88600891 | ||
| A fast-responsive fluorescent probe for sensitive detection of graphene oxide based on MoS2 quantum dots | Q88989464 | ||
| Highly efficient cascading synergy of cancer photo-immunotherapy enabled by engineered graphene quantum dots/photosensitizer/CpG oligonucleotides hybrid nanotheranostics | Q92629446 | ||
| P433 | issue | 1 | |
| P921 | main subject | erlotinib | Q418369 |
| P304 | page(s) | 76 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | Journal of Nanobiotechnology | Q15752156 |
| P1476 | title | Functionalized MoS2-erlotinib produces hyperthermia under NIR | |
| P478 | volume | 17 |
Search more.